ReviewCurrent urology reports2025
A Comprehensive Review of Artificial Urinary Sphincters: History, Current Utilization, and Future Innovations.
Review in Current urology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evolving Trends and Perioperative Outcomes of Surgical Treatment for Male Stress Urinary Incontinence: Results from the GRAND Study Register.European urology open science · 2026Article
- [Artificial urinary sphincter: contemporary overview of evidence, long-term outcomes, and clinical practice].Urologie (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis narrative review summarizes the evolution of the artificial urinary sphincter (AUS) and its role in treating male stress urinary incontinence (SUI). This review discusses the history of AUS and changes that have helped drive current and future developments in AUS innovation. RECENT
findingsRecent AUS models have addressed many shortcomings of prior devices designed for the treatment of SUI. However, the need for manual pumping as well as the risks of erosion, infection, and malfunction remain areas of concern, prompting innovative transformations to AUS development. The AUS is the gold standard and most effective treatment for male SUI. Currently available devices have limitations, especially in patients with reduced manual dexterity and cognition. Additionally, there are inherent risks for urethral erosion and device failure. Despite the efficacy and success of modern-day AUS devices, there is still opportunity for innovation in the AUS market. This includes the advent of electronic assisted devices as well as adjustable and variable pressure mechanisms to create dynamic artificial sphincters that minimize complications while maximizing patient outcomes.
Indexed as
Identifiers
40705134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.